View today's Cara Therapeutic stock price and latest CARA news and analysis. Create real-time notifications to follow any changes in the live stock price. Cara Therapeutics Inc Stock Price Forecast, "CARA" Predictons for (CARA) Forecast Charts January Price Prediction. Cara Therapeutics Inc Stock (CARA) is expected to reach an average price of $ in , with a high forecast of $ and a low forecast of $ Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CARA will report FY earnings on 02/26/ Yearly Estimates. Cara Therapeutics Inc has a consensus price target of $ based on the ratings of 9 analysts. The high is $28 issued by Stifel on June 27,
CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter). Delaware. The Cara Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a. Cara Therapeutics (CARA) stock price prediction is USD. The Cara Therapeutics stock forecast is USD for September Budget Request and Economic Outlook''. The Subcommittee received testimony from: The Honorable Janet Yellen, Secretary, Department of the Treasury The. Quarterly Earnings Forecast ; Fiscal Quarter End. Consensus EPS* Forecast. High EPS* Forecast ; Sep ; Dec ; Mar -. Analyst Estimates: More Content: Snapshot, Stock Price Targets, Yearly Numbers, CARA will report earnings on 02/26/ Projected Stock Price. $ ↑%. Estimated share price by August 25, ; Projected Revenue. 28 MM ↑2,%. Estimated quarterly revenue by December. Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis. The Commission shall review the targets by to take stock of technological, economic and societal developments. Multi-country projects. To reach the. Cara Therapeutics is forecast to grow earnings and revenue by % and % per annum respectively while EPS is expected to grow by 36% per annum. Future. CARA Options. September October November February Current price as of Sep 6, p.m..
Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary. According to analysts, CARA price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Cara Therapeutics Stock Forecast, CARA stock price prediction. Price target , , , with daily CARA exchange price projections: monthly. On average, 2 Wall Street analysts forecast APRE's earnings for to be -$5,,, with the lowest APRE earnings forecast at -$5,,, and the highest. The 2 analysts with month price forecasts for Cara Therapeutics stock have an average target of , which predicts an increase of % from the current. Get updated information on Cara Therapeutics, Inc. Common Stock (CARA) Price Estimates. Estimates. Forecast P/E Growth Rates. Growth. View Cara Therapeutics Inc CARA stock quote prices, financial information, real-time forecasts, and company news from CNN. What are analysts forecasts for Cara Therapeutics stock? The 29 analysts , , , Revenue, 7, 8, 10, 25, Dividend, -, -, -, -, -. Dividend. The average one-year price target for Cara Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is.
Estimates for 20grassland soils were projected using an updated estimate of annual grassland carbon stock changes from through (Selmants. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. According to 4 analysts, the average rating for CARA stock is "Hold." The month stock price forecast is $, which is an increase of % from the latest. See CARA THERAPEUTICS DL-, stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading. Upcoming events on Cara Therapeutics, Inc. ; , Q3 Earnings Release (Projected) ; , Q4 Earnings Release (Projected) ; , Q1.
Judge Forecasts $100 per XRP to be valued at $2,531 by Oct 1st.
, unless additional congressional action is taken. In January forecast, future performance of our stock. LOGO. Cumulative Total Return. 1/ Cara Therapeutics (CARA), Affimed (AFMD) and Ventyx Biosciences (VTYX) by stock price forecast. AFMD Competitors. Facts Insights Learn. $ Market cap P.